Scholarlink

Patients with OTX2 mutations have highly variable phenotypes, as the transcription factor is key in the development of retinal, pituitary gland, inner ear, and craniofacial structures. There are two recognized syndromes caused by OTX2 mutations: syndromic microphthalmia type 5 (MCOPS5), and combined pituitary hormone deficiency type 6 (CPHD6).

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

OTX2 Syndromes

  • 章节

  • 发表日期：

    2025年

查看全文
  • Chloe Li,
  • Stephen Tsang,
  • Tarun Sharma,
  • Vlad Diaconita

摘要

Patients with OTX2 mutations have highly variable phenotypes, as the transcription factor is key in the development of retinal, pituitary gland, inner ear, and craniofacial structures. There are two recognized syndromes caused by OTX2 mutations: syndromic microphthalmia type 5 (MCOPS5), and combined pituitary hormone deficiency type 6 (CPHD6).